Former Biofourmis CEO to be charged over alleged fraud and falsified invoices worth US$16.5 million
BT understands the accused to be the healthcare startup’s founder and former chief executive Kuldeep Singh Rajput
[SINGAPORE] The former director and chief executive officer of healthcare startup Biofourmis Holdings is set to be charged in court on Feb 4, 2026, for his alleged involvement in a series of financial crimes, Singapore Police Force (SPF) said in a news release on Tuesday.
The individual will be charged with falsification of accounts, fraud by false representation, and forgery for the purpose of cheating.
The Business Times understands the accused to be the company’s founder and former CEO Kuldeep Singh Rajput, who abruptly stepped down from his position in August 2023.
The accused allegedly instigated his staff to falsify company invoices between Aug 18, 2021, and Feb 28, 2022. These documents purportedly showed that Biofourmis Singapore had rendered services worth almost US$16.5 million to the Ministry of Health.
Furthermore, the police alleged that between Mar 28 and Apr 25 in 2022, Rajput “fraudulently made – and also abetted by instigating the making of – false representations concerning (Bifourmis Holdings) and its subsidiaries”.
He was also alleged to have forged an employee stock option plan offer letter. This act was reportedly carried out for the purpose of cheating a bank in relation to an intended funds transfer.
If convicted of fraud by false representation or abetting such fraud, Rajput faces an imprisonment term of up to 20 years, a fine, or both per charge.
For the charges involving the falsification of accounts or forgery for the purpose of cheating, he faces up to 10 years in prison, a fine, or both for each instance.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
